NCT07337538 Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.
| NCT ID | NCT07337538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Baghdad |
| Condition | Implant Stability |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-01-14 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-01-14 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are: which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate. 20 participant will receive 40 mini implant bilaterally (20 in one side of 1.6mm, the other side 20 of 2mm). participants will be asked to record visual analog scale (VAS) for 3 nights monitored monthly by the investigator.
Eligibility Criteria
Inclusion Criteria: 1. Individuals aged between 15 and 38 years. 2. Patients currently undergoing orthodontic treatment with fixed appliances who require mini-implant placement in the upper buccal posterior region (IZC) for full-arch distalization or en-masse retraction. 3. Patients willing and able to adhere to the study protocol. 4. Recommended for the use of bilateral mini-implants. Exclusion Criteria: * Syndromic conditions, facial trauma, or previous bone-related surgery.
Contact & Investigator
Ali J. Al Ameri, BDS.
PRINCIPAL INVESTIGATOR
University of Baghdad
Frequently Asked Questions
Who can join the NCT07337538 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 38 Years, studying Implant Stability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07337538 currently recruiting?
Yes, NCT07337538 is actively recruiting participants. Contact the research team at Ali.Fahd2403@codental.uobaghdad.edu.iq for enrollment information.
Where is the NCT07337538 trial being conducted?
This trial is being conducted at Baghdad, Iraq, Baghdad, Iraq.
Who is sponsoring the NCT07337538 clinical trial?
NCT07337538 is sponsored by University of Baghdad. The principal investigator is Ali J. Al Ameri, BDS. at University of Baghdad. The trial plans to enroll 20 participants.